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INTRODUCTION:  Gastrointestinal  stromal  tumours  (GISTs)  are  uncommon  intra-abdominal  tumours.
These  tumours  tend  to  arise  with  a  higher  frequency  in  the stomach  and  the small  bowel.  In  fewer
than  5%  of  cases,  they  originate  primarily  from  extra-gastrointestinal  tumours  (EGISTs).  Gastrointestinal
stromal  tumour  of  the  pancreas  is  very  rare.  Only  few  cases  have  been  published.  We  report  the  ﬁrst  case
of  stromal  tumour  of  the  pancreas  with  concomitant  pancreas  divisum.
PRESENTATION OF  CASE:  A 39-year-old  male  who  presented  with  constipation  and  abdominal  pain.  A
computerized  tomography  demonstrated  a  9  cm pancreatic  mass,  without  liver  lesions.  A  Whipple  pro-
cedure  with  segmental  colectomy  was  performed  with  success.  After 24  months  follow  up, the  patient  is
doing  well  and  disease-free.
DISCUSSION: Mesenchymal  tumours  of  the  pancreas  are  extremely  rare, accounting  for  less  than  1% of  allancreas divisum pancreatic  tumours.  The  endoscopic  ultrasound  is helpful  for diagnosis.  Surgical  resection  with  negative
pathologic  margins  remains  the treatment  of  choice.
CONCLUSION: in  our  knowledge,  this  is  the ﬁrst  case  of pancreatic  GIST  with  pancreas  divisum.  Although
pancreatic  GISTs  are  uncommon  tumours,  they  must  be  considered  in  the  differential  diagnosis  of  solid
pancreatic  lesions.  Even  though  the  tumour  can  be evaluated  as  high  risk,  treatment  must  be aggressive
in  order  to improve  survival  rate.
gical © 2012 Sur
. Introduction
Gastrointestinal stromal tumours (GISTs) have been a subject
f controversy for the last decade.1 Extra-gastrointestinal stromal
umours (EGISTs) are rare. They are found in the omentum, mesen-
ery, retroperitoneum or other intra-abdominal sites.2 Pancreatic
ISTs are extremely rare. Only few cases were reported in the
iterature.3 We  describe here the ﬁrst case of pancreatic GIST with
ancreas divisum.
.  Case report
A  39 years old male presented with 1-month history of weight
oss of 10 kg, epigastric pain, anorexia and constipation. The phys-
cal examination showed a good nutritional status, epigastric
enderness, and low-grade pyrexia (37.5 ◦C). The abdomen was dis-
ended but soft and bowel sounds were present. Rectal examination
as normal. Laboratory values on admission demonstrated a raisederum Amylasemia (500 U/l), a lipase levels (430 U/l), white blood
ell count (10.3 × l09/l), and anaemia haemoglobin (10.8 g/dl). Rou-
ine laboratory tests showed a Serum CA 19-9 and CEA levels were
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29 U/ml and 2 ng/ml, respectively. Colonoscopy showed no abnor-
malities. Ultrasound examination showed a hypoechogenic tumour
of the head of pancreas with cholelithiasis. The pancreas was not
clearly seen. An upper GI endoscopy was performed and it revealed
only mild antral gastritis and duodenitis. The exploration of the
papilla was  difﬁcult. Computed tomography demonstrated a 9 cm
low-density mass with a ﬂuid level (Figs. 1 and 2), in the region
of the pancreatic head, which compressed the transverse colon. A
pancreaticoduodenectomy with segmental colectomy and chole-
cystectomy was  performed (Fig. 3). Macroscopic examination of
the operative specimen disclosed a 10-cm multiloculated tumour
containing necrosis components. The second portion of the duode-
num showed three oriﬁces in papilla and the examination of these
ducts shows an arborizing ventral pancreatic duct without connec-
tion to the dorsal duct (Fig. 4). Microscopic examination showed
a stromal tumour of the pancreas inﬁltrating the pericolonic tis-
sue and no evidence of colonic involvement was  seen. There was
no metastatic spread in the 10 lymph nodes examined. Histo-
logical examination described a pancreatic mesechymal fusiform
tumour with free margins. The tumour was composed of spindle
cells with a mitotic rate that was  less than 5 per 50 high power
ﬁelds (Fig. 5). Immunophenotyping stain was  strongly positive for
CD34 and CD117 (Fig. 6). Treatment based adjuvant imatinib was
Open access under CC BY-NC-ND license.prescribed. The postoperative course was  uneventful. The follow
up, performed 3, 6, 24 months later, showed complete recovery,
without any sign of recurrence of the disease.
 BY-NC-ND license.
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Fig. 1. Computerized tomogram without and with injection intra venous contrast:
heterogenous  mass associated with necrosis component in the right upper quadrant
measuring 9 cm × 7 cm × 5 cm.
Fig. 2. Computerized tomogram without and with injection intra venous contrast:
heterogenous  mass associated with necrosis component in the right upper quadrant
measuring 9 cm × 7 cm × 5 cm.
Fig. 3. Specimen resection of duodenopancreatectomy with segmental colectomy.
Fig. 4. Open specimen resection: 3 oriﬁces in second portion of the duodenum.Fig. 5. H&E stain demonstrated spindle cells with mitotic rate less than 5 per 50
high power ﬁelds.
3. Discussion
Gastrointestinal stromal tumours (GISTs) are uncommon mes-
enchymal tumours of the gastro-intestinal (GI) tract.4 Described
the ﬁrst time by Schaldenbrand and Appelman in 1984,5 they
account for less than 5% of all gastrointestinal tumours.6 GISTs
involve most commonly the stomach, followed by the small intes-
tine, the colon, the rectum, and the oesophagus.7 They were also
occasionally reported in extragastrointestinal sites, such as uri-
nary bladder, gallbladder omentum and mesentery.2 Mesenchymal
Fig. 6. Immunohistochemistry demonstrating strong immuno-expression of CD
117.
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umours of the pancreas are extremely rare, accounting for less
han 1% of all pancreatic tumours, and most of them have been
eported in small series or as single case reports. This group of
ancreatic tumours includes leiomyosarcoma, malignant ﬁbrous
istiocytoma, liposarcoma, rhabdomyosarcoma, hemangiopericy-
oma, schwannoma and solitary ﬁbrous tumour.8 Gastrointestinal
tromal tumours of the pancreas are very rare.3,9 Only eight cases
ave been published.3,9–12 In our knowledge, we describe here
he ﬁrst case of a pancreatic GIST with pancreas divisum. Pan-
reas divisum is a congenital anatomical anomaly characterized
y the lack of fusion of the ventral and dorsal parts of the pan-
reas during the eighth week of faetal development. This condition
s found in 5–14% of the general population.2 Many pancreatic
umours had been reported in association with these congenital
nomalies such as adenocarcinoma, carcinoid tumour, intraductal
apillary mucinous tumour and gastrointestinal stromal tumour
f the papilla.13–15 In our case the diagnosis of pancreas divi-
um was done after examination of specimen resection. Pancreas
ivisum is not reliably detected by such scans. In most cases,
ancreas divisum is best diagnosed by endoscopic retrograde
holangiopancreatography, magnetic resonance cholangiopancre-
tography or endoscopic ultrasonography. Although magnetic
esonance cholangiopancreatography has limited availability and
igh cost, it is rapidly becoming the noninvasive test of choice
o diagnose the condition.13–15 However, endoscopic retrograde
holangiopancreatography remains the test of choice to diagnose
r manage pancreas divisum for most patients.
There are several possibilities regarding the histogenesis of
GISTs. First, these tumours may  originate from the gastrointesti-
al tract and subsequently move outside the gastrointestinal tract,
ncluding the retroperitoneum. Second, these tumours may  arise
rom mesenchymal elements outside the gastrointestinal tract that
an show the phenotype of interstitial cells of Cajal. Further studies
re needed to elucidate their histogenesis. With regard to the prog-
osis of EGISTs, features that have been associated with a shorter
nterval to either metastasis or death include mitotic activity (more
han 2 mitoses in 50 high-power ﬁelds) and cellularity.2,7,11 They
re usually asymptomatic depending on the location and the size of
he tumour.3 The clinical symptoms include abdominal pain, ﬂatu-
ence, ileus, bleeding, anaemia, and weight loss. It can be diagnosed
ncidentally from radiologic imaging.10,16 In the case reported here,
he clinical presentation could be attributed to chronic pancreatitis
ssociated with pancreas divisum or to the size of the tumour and
he colonic compression.
Endoscopic ultrasound guided FNA is helpful for diagnosis of
ancreatic lesions.3,9,17 The size of the tumour and mitotic index
as been suggested as prognostic factors of malignancy.
Tumours of the pancreatoduodenal complex present many tech-
ical challenges because of the anatomy of the region, unlike
umours of the small intestine or stomach where wide margins
an be achieved without a signiﬁcant technical challenge. Surgical
esection including with negative pathologic margins of resection
re the treatment of choice for GISTs.18–20 Lymphatic spread of
ISTs is uncommon; therefore, a systematic lymph node dissec-
ion is not a standard surgical management. In our patient, we
erformed a pancreaticoduodenectomy with partial colectomy to
e sure to have a negative margin. Even if the morbidity associ-
ted with Whipple procedure is high, it represents the key of the
reatment. Although some authors reported a long-term survival
f pancreatic GIST treated surgically without chemotherapy, this
rug must be proposed as an adjuvant in the high-grade tumours,
s our patient.21,22There is a few data with regard to predicting the malignant
otential of EGIST. Reith et al. analysed 48 EGISTs in order to
etermine the particularities of theses tumours.12 They suggest in
heir study that the majority of these patients had an aggressive
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tumour  and developed metastatic disease tumours within a short
period.2
4. Conclusion
To our knowledge, this is the ﬁrst case report of a pancreatic GIST
with pancreas divisum. Although these are uncommon, pancreatic
GIST should be included in the differential diagnosis of masses of
the pancreas. Even though the tumour can be evaluated as high risk,
treatment must be aggressive including different complex surgical
methods and chemotherapy in order to improve survival rate.
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